Fowl Cholera in Poultry: Etiology, Clinical Signs, Diagnosis, and Control
Introduction
Fowl cholera, also known as avian pasteurellosis, is a highly contagious bacterial disease affecting domestic poultry, waterfowl, and numerous wild bird species. The disease is caused by the Gram-negative coccobacillus Pasteurella multocida and represents a significant economic burden to the poultry industry worldwide due to high morbidity, mortality, and production losses. This article provides a detailed, publication-grade review of the etiology, epidemiology, clinical signs, pathological findings, diagnostic approaches, and control measures for fowl cholera in poultry.
Etiology
The Causative Agent: Pasteurella multocida
Fowl cholera bacterial etiology is exclusively attributed to Pasteurella multocida, a nonmotile, facultatively anaerobic, Gram-negative coccobacillus belonging to the family Pasteurellaceae. The organism exhibits bipolar staining when treated with methylene blue or Giemsa stain, a characteristic that aids in preliminary microscopic identification. P. multocida is catalase and oxidase positive and ferments carbohydrates without gas production. The bacterium possesses a polysaccharide capsule that is a critical virulence factor, protecting the organism from phagocytosis and complement-mediated lysis. Capsular serogroups A, B, D, E, and F have been identified, with serogroup A being the most common cause of fowl cholera in poultry. Somatic lipopolysaccharide (LPS) antigens further classify the organism into 16 serotypes (1 through 16) using the Heddleston scheme. Serotypes 1, 3, and 4 are frequently associated with avian disease.
Virulence Factors
The pathogenicity of P. multocida is multifactorial. The capsule, particularly hyaluronic acid in serogroup A, inhibits phagocytosis. Lipopolysaccharide (LPS) acts as an endotoxin, inducing fever, inflammation, and septic shock. Outer membrane proteins (OMPs) and fimbriae facilitate adhesion to host epithelial cells. The bacterium also produces siderophores for iron acquisition, which is essential for growth within the host. A key virulence factor is the Pasteurella multocida toxin (PMT), a potent mitogen that activates intracellular signaling pathways, leading to cellular proliferation and tissue damage. PMT is primarily associated with serogroup D strains causing atrophic rhinitis in swine, but its role in avian disease is less defined.
Epidemiology
Host Range and Susceptibility
Fowl cholera affects a wide range of avian species. Chickens, turkeys, ducks, geese, and game birds such as pheasants and quail are highly susceptible. Turkeys are particularly vulnerable, often experiencing acute, peracute outbreaks with high mortality. Waterfowl can serve as asymptomatic carriers, introducing the pathogen into domestic flocks. The disease is distributed globally, with higher prevalence in regions with intensive poultry production and poor biosecurity.
Transmission and Risk Factors
Transmission occurs horizontally through direct contact with infected birds, ingestion of contaminated feed or water, and inhalation of aerosolized respiratory secretions. The bacterium can survive for weeks in organic material, water, and soil, facilitating indirect transmission via fomites, equipment, and personnel. Stress factors such as overcrowding, poor ventilation, nutritional deficiencies, concurrent infections, and sudden environmental changes predispose flocks to outbreaks. Carrier birds, which harbor the organism in their nasal sinuses or tonsils without clinical signs, are a primary reservoir for recurrent outbreaks.
Clinical Signs
The clinical presentation of fowl cholera varies with the virulence of the P. multocida strain, host species, and immune status of the flock. Three main forms are recognized: peracute, acute, and chronic.
Peracute Form
The peracute form is most common in turkeys and is characterized by sudden death without premonitory signs. Birds are found dead in good body condition. Mortality can reach 50% or higher within 24 to 48 hours.
Acute Form
The acute form is typical in chickens and presents with a rapid onset of clinical signs. Affected birds exhibit fever (up to 44 degrees Celsius), depression, anorexia, ruffled feathers, and cyanosis of the comb and wattles. Respiratory signs include dyspnea, rales, and mucoid nasal discharge. Oral and nasal mucous membranes may be congested. Diarrhea is common, with feces ranging from greenish to yellowish and occasionally containing blood. Egg production drops sharply in laying flocks. Mortality rates in acute outbreaks range from 20% to 50%.
Chronic Form
The chronic form develops in birds that survive the acute phase or in flocks with low-virulence strains. Clinical signs are localized and include swollen wattles (wattle edema), conjunctivitis, sinusitis, torticollis (due to otitis media or meningitis), and lameness from septic arthritis or osteomyelitis. Chronic respiratory signs such as rales and nasal discharge may persist.
Pathology
Gross Lesions
Postmortem examination reveals characteristic lesions. In peracute cases, few gross lesions are present aside from generalized congestion. In acute cases, petechial and ecchymotic hemorrhages are observed on the epicardium, serosal surfaces of the abdominal viscera, and in the musculature. The liver is enlarged, friable, and studded with multiple small, pale, necrotic foci (miliary necrosis). The spleen is swollen and congested. The lungs may be edematous and congested. The intestines show catarrhal to hemorrhagic enteritis. In chronic cases, localized lesions include caseous or fibrinous exudate in the wattles, sinuses, and joints. Fibrinous pericarditis and airsacculitis may be present.
Histopathology
Microscopic examination of the liver reveals multifocal coagulative necrosis with infiltration of heterophils and macrophages. Fibrin thrombi are often present in hepatic sinusoids and pulmonary capillaries. In the spleen, lymphoid depletion and necrosis of ellipsoids are observed. The lungs show congestion, edema, and fibrin exudation. Chronic lesions are characterized by granulomatous inflammation with central caseous necrosis surrounded by epithelioid macrophages and fibrous connective tissue.
Diagnosis
A definitive diagnosis of fowl cholera requires laboratory confirmation. A combination of clinical signs, gross pathology, and histopathology provides strong presumptive evidence.
Sample Collection
Appropriate samples for diagnostic testing include liver, spleen, lung, bone marrow, heart blood, and exudate from swollen wattles or joints. Samples should be collected aseptically from freshly dead or euthanized birds and transported to the laboratory under refrigeration.
Microscopic Examination
Impression smears from liver, spleen, or blood stained with methylene blue or Giemsa stain reveal bipolar, Gram-negative coccobacilli. This rapid test can provide a preliminary diagnosis within minutes.
Culture and Isolation
P. multocida grows on standard bacteriological media such as blood agar or MacConkey agar (though growth on MacConkey is variable). Colonies are small, grayish, and nonhemolytic on blood agar after 24 to 48 hours of incubation at 37 degrees Celsius in a 5% carbon dioxide atmosphere. The organism is identified by its characteristic colony morphology, Gram stain reaction, and biochemical profile (catalase positive, oxidase positive, indole positive, urease negative).
Molecular Diagnostics
Polymerase chain reaction (PCR) assays targeting species-specific genes, such as the KMT1 gene, provide rapid and sensitive detection of P. multocida directly from clinical samples. Multiplex PCR assays can simultaneously identify capsular serogroups and somatic serotypes, facilitating epidemiological investigations. Real-time PCR (qPCR) offers quantitative data and is increasingly used for high-throughput screening.
Serological Tests
Serological assays, including enzyme-linked immunosorbent assay (ELISA) and agglutination tests, are used for serotyping and for monitoring vaccine responses in flocks. These tests are less useful for acute diagnosis due to the time required for seroconversion.
Differential Diagnosis
Fowl cholera must be differentiated from other acute septicemic diseases of poultry, including highly pathogenic avian influenza (HPAI), Newcastle disease (ND), fowl typhoid (Salmonella Gallinarum), pullorum disease (Salmonella Pullorum), and colibacillosis (Escherichia coli). Chronic forms must be differentiated from infectious coryza (Avibacterium paragallinarum), mycoplasmosis, and aspergillosis.
flowchart TD
A[Clinical Signs: Sudden death, fever, cyanosis, diarrhea], > B[Postmortem Examination]
B, > C{Gross Lesions: Hepatic necrosis, petechiae, pneumonia?}
C, Yes, > D[Impression Smear: Bipolar rods?]
C, No, > E[Consider other diagnoses: HPAI, ND, Salmonellosis]
D, Positive, > F[Confirmatory Testing]
D, Negative, > G[Culture on Blood Agar]
G, > H[Biochemical Identification: Catalase+, Oxidase+, Indole+]
H, > I[PCR: KMT1 gene detection]
I, > J[Definitive Diagnosis: Fowl Cholera]
F, > J
J, > K[Serotyping: Capsular & Somatic]
K, > L[Epidemiological Investigation & Control]
Treatment
Antimicrobial Therapy
Treatment of fowl cholera relies on the administration of antimicrobial agents. Historically, tetracyclines (e.g., oxytetracycline, chlortetracycline), sulfonamides, and penicillin have been effective. However, antimicrobial resistance in P. multocida is an increasing concern. Fluoroquinolones (e.g., enrofloxacin) and florfenicol are commonly used in many regions, but their use should be guided by antimicrobial susceptibility testing (AST). Treatment is most effective when initiated early in the course of the disease. Water-soluble formulations are preferred for mass medication of flocks. The duration of treatment is typically 5 to 7 days.
Supportive Care
Supportive measures include improving ventilation, reducing stocking density, correcting nutritional deficiencies, and providing clean water. Removal of dead and moribund birds reduces environmental contamination and disease transmission.
Control and Prevention
Biosecurity
Strict biosecurity is the cornerstone of fowl cholera prevention. This includes controlling access to poultry houses, implementing all-in/all-out production systems, cleaning and disinfecting equipment and facilities, and preventing contact between domestic poultry and wild birds, especially waterfowl. Rodent and pest control programs are essential as these animals can mechanically transmit the bacterium.
Vaccination
Vaccination is a key component of control programs in endemic areas. Both inactivated (bacterin) and live attenuated vaccines are available. Inactivated vaccines, typically containing multiple serotypes, are administered parenterally and require booster doses. They provide protection against homologous serotypes but may not be fully protective against heterologous strains. Live attenuated vaccines, such as the CU (Clemson University) strain, are administered via drinking water or wing-web inoculation. They induce both humoral and cell-mediated immunity and provide broader cross-protection. However, live vaccines retain some virulence and can cause disease in turkeys and immunocompromised birds. Autogenous vaccines, prepared from field isolates recovered from the affected flock, are used when commercial vaccines fail to provide adequate protection.
Eradication
In flocks with recurrent outbreaks, depopulation followed by thorough cleaning, disinfection, and a fallow period may be necessary to eliminate the pathogen. Repopulation with P. multocida free stock is then performed.
Fowl Cholera in Hindi
Fowl cholera is known as "मुर्गी हैजा" (Murghi Haiza) in Hindi. The disease is caused by the bacterium Pasteurella multocida (पाश्चरेला मल्टोसिडा). Clinical signs include sudden death, fever, greenish diarrhea, and swelling of the wattles. Diagnosis is confirmed by laboratory culture and PCR. Control relies on biosecurity, vaccination, and antimicrobial therapy under veterinary supervision.
Conclusion
Fowl cholera remains a major threat to poultry health and productivity worldwide. A thorough understanding of its etiology, epidemiology, and pathogenesis is essential for effective diagnosis and control. Integrated management strategies combining rigorous biosecurity, strategic vaccination, and prudent antimicrobial use are critical for minimizing the impact of this disease. Ongoing surveillance for antimicrobial resistance and emerging serotypes is necessary to adapt control programs to evolving challenges.
References
- Christensen, H., & Bisgaard, M. (2008). The genus Pasteurella. In Pasteurellaceae: Biology, Genomics and Molecular Aspects. Caister Academic Press.
- Glisson, J. R., Hofacre, C. L., & Christensen, J. P. (2008). Fowl cholera. In Diseases of Poultry, 12th edition. Blackwell Publishing.
- Harper, M., Boyce, J. D., & Adler, B. (2006). Pasteurella multocida pathogenesis: 125 years after Pasteur. FEMS Microbiology Letters, 265(1), 1-10.
- Heddleston, K. L., Gallagher, J. E., & Rebers, P. A. (1972). Fowl cholera: gel diffusion precipitin test for serotyping Pasteurella multocida from avian species. Avian Diseases, 16(4), 925-936.
- Mohamed, M. A., Mohamed, M. W., Ahmed, A. I., & Ibrahim, A. A. (2012). Pasteurella multocida in backyard chickens in Upper Egypt: incidence, serotypes, and antimicrobial resistance. Veterinary World, 5(8), 476-480.
- Shivachandra, S. B., Viswas, K. N., & Kumar, A. A. (2011). A review of hemorrhagic septicemia in cattle and buffalo. Animal Health Research Reviews, 12(1), 67-82.
- Townsend, K. M., Boyce, J. D., Chung, J. Y., Frost, A. J., & Adler, B. (2001). Genetic organization of Pasteurella multocida cap loci and development of a multiplex capsular PCR typing system. Journal of Clinical Microbiology, 39(3), 924-929.
- Wilkie, I. W., Harper, M., Boyce, J. D., & Adler, B. (2012). Pasteurella multocida: diseases and pathogenesis. Current Topics in Microbiology and Immunology, 361, 1-22.
Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.